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Introduction {#sec001}
============

The APOBEC3s (apolipoprotein B mRNA-editing enzyme, catalytic subunit 3 or A3s) are innate immune effectors restricting many exogenous viruses and endogenous retroelements \[[@ppat.1008718.ref001]--[@ppat.1008718.ref003]\]. The human genome encodes for seven A3 genes (namely A3A, B, C, D, F, G and H), with several spliced transcripts and allelic variants for each. These seven genes originate from gene duplications and rearrangements that have occurred during mammalian evolution and represent a classic example of the virus-host arms race \[[@ppat.1008718.ref004]\]. The A3s are cytidine deaminases that convert cytosine to uracil present in single stranded DNA or RNA. Such editing on viral genomes generally results in C to T (or U) transition after replication of the genome. The A3s preferably mutate cytosine in a 5'TC dinucleotide context with the notable exception of A3G that favors a C before the mutated C \[[@ppat.1008718.ref005]\].

The antiviral activity of the A3s has been first reported for the reverse transcribing viruses HIV-1 (human immunodeficiency virus-1), HTLV-1 (human T-lymphotropic virus-1) and HBV (Hepatitis B virus) \[[@ppat.1008718.ref006]--[@ppat.1008718.ref008]\]. Editing occurs during reverse transcription on the negative strand leading to G to A mutations on the positive strand \[[@ppat.1008718.ref009]--[@ppat.1008718.ref014]\]. Subsequently, A3-introduced mutations have been reported on various double-stranded DNA (EBV for Epstein-Barr virus, HSV-1 for herpes simplex virus-1, α-HPVs for alpha human papillomaviruses, BK PyV for BK polyomavirus), single-stranded DNA (TT virus) and single-stranded RNA (HCoV-NL63 for human coronavirus NL63) viruses \[[@ppat.1008718.ref015]--[@ppat.1008718.ref019]\]. It is important to note that the antiviral action of the A3 proteins is not based solely on their deaminase activity. Deaminase-independent restriction has been demonstrated against endogenous retroelements, reverse transcribing viruses, adeno-associated viruses and many RNA viruses (HCV for hepatitis C virus, RSV for respiratory syncytial virus, HCoV-NL63, mumps virus and measles virus) \[[@ppat.1008718.ref020]--[@ppat.1008718.ref025]\].

The co-evolution between virus and host leads to the selection of viral proteins capable of countering the restriction effect of A3s. HIV-1 encodes for the Vif protein which promotes A3G degradation \[[@ppat.1008718.ref026]\]. HTLV-1 evades A3G restriction by excluding A3G from virions \[[@ppat.1008718.ref027]\]. BORF2 protein from EBV inhibits A3B deaminase activity and re-locates it far from viral replication centers \[[@ppat.1008718.ref028]\]. Besides these active viral mechanisms targeting A3 proteins, some viruses have evolved passive strategies to limit A3 restriction. One such strategy is the depletion of A3-favored motifs from the viral genome. By repetitive exposure to A3 activity, non-lethal mutations can accumulate in the genomic sequence leading to the under-representation of the motifs favored by A3s. This under-representation of A3-favored motifs is called A3 evolutionary footprint. Thus, the 5'TC dinucleotide motif is under-represented in the genome of α-HPVs and BK polyomavirus \[[@ppat.1008718.ref017],[@ppat.1008718.ref029]\]. Similarly, 5'TC and 5'CC (favored by A3G) motifs are under-represented in the negative strand of LTR (long terminal repeat) and non-LTR endogenous retroelements \[[@ppat.1008718.ref030]\]. Conflicting data have been reported regarding evidence of an A3 footprint on the HIV-1 genome \[[@ppat.1008718.ref031],[@ppat.1008718.ref032]\]. Recently, an under-representation of certain A3 motifs has been shown in the genome of the γ-herpesviruses EBV and KSHV (Kaposi sarcoma herpes virus) \[[@ppat.1008718.ref033]\]. Finally, codon usage in coronaviruses suggests that cytosine deamination is an important biochemical force which shapes the evolution of these viruses \[[@ppat.1008718.ref034]\].

Different bioinformatics approaches have been used to search for evidence of an A3 evolutionary footprint in viral genomes \[[@ppat.1008718.ref017],[@ppat.1008718.ref029]--[@ppat.1008718.ref033],[@ppat.1008718.ref035],[@ppat.1008718.ref036]\]. In this study, we adapted and extended the Warren *et al*. approach \[[@ppat.1008718.ref029]\] to carry out a general screening for the A3 footprint of the genomes of all currently annotated human viruses. We first demonstrate the sensitivity and specificity of our approach: i. an A3 footprint is detected in viruses which have already been shown to be depleted for A3-targeted motifs; ii. no A3 footprint has been reported in viruses from animals lacking A3 genes. We showed that as much as 22% of currently annotated human viral species are shaped by the A3 selection pressure. We confirmed previous reports showing that papillomaviruses and polyomaviruses are generally strongly footprinted by the A3s. Among the most A3-footprinted viruses, we identified autonomous parvoviruses and in particular the B19 erythroparvovirus as deeply cleansed for A3-favored motifs. Importantly, we showed that the A3 footprint observed in coronaviruses is limited to the endemic viruses and absent from the zoonotic MERS-CoV (middle east respiratory syndrome coronavirus), SARS-CoV-1 (severe acute respiratory syndrome coronavirus) and SARS-CoV-2 viruses. We also carried out a gene-specific A3 footprint search and identified local footprint on EBV and adenoviruses consistent with genome targeting during the initiation of replication.

Results {#sec002}
=======

Definition of the A3 footprint {#sec003}
------------------------------

The A3 footprint is defined as the under-representation of A3-targeted motifs. Different approaches have been devised to estimate the over/under-representation of a given motif \[[@ppat.1008718.ref017],[@ppat.1008718.ref029]--[@ppat.1008718.ref033],[@ppat.1008718.ref035],[@ppat.1008718.ref036]\].

Firstly, and because most of the A3 proteins (A3A, A3B, A3C, A3F and A3H) favors deamination of cytosine to uracil in a 5'TC dinucleotide context, we have chosen to look for the under-representation of the 5'TC motif. Moreover, as originally developed by Warren *et al*., we refined our analysis by distinguishing the position of the 5'TC motif relative to the coding sequence. Namely, we differentiate three K-mers containing the TC motif; one K-mer having the C in the first position of the codon (NNT[C]{.ul}NN), one K-mer having the C in the second position of the codon (T[C]{.ul}N) and one K-mer having the C in the third position of the codon (NT[C]{.ul}). A3-introduced deamination of cytosine in viral genome produces an uracil that can be fixed in the form of thymidine after genome replication. This transition will have different impacts depending on the position of the mutated C. The C to T mutation will be non-synonymous if the C is at the first or second position of the codon ([Fig 1A](#ppat.1008718.g001){ref-type="fig"}, NNTCNN and TCN K-mers). However, if the mutated C occupies the third position of the codon, the C to T mutation will always be synonymous ([Fig 1A](#ppat.1008718.g001){ref-type="fig"}, NTC K-mer). Therefore, A3-driven natural selection should deplete more intensively NTC codons than TCN or NNTCNN motifs (as in those cases the C to U mutation will impact the encoded amino acid). Obviously, A3 editing can also target the template strand where a C to T mutation will translate into G to A transition in the coding strand. Again, this transition will have different impacts depending on the position of the mutated G. The G to A mutation will be non-synonymous if the G is at the first or second position of the codon ([Fig 1A](#ppat.1008718.g001){ref-type="fig"}, GAN and NGA K-mers). However, if the mutated G occupies the third position of the codon the mutation will be most of the time synonymous ([Fig 1A](#ppat.1008718.g001){ref-type="fig"}, NNGANN K-mer). Because synonymous mutations are presumably more likely to be retained than non-synonymous, we define the A3 footprint (with the exception of A3G-induced footprint) as the depletion of NTC or NNGANN K-mers. Calculation of observed vs expected K-mer ratio has been adapted from Warren *et al*. and detailed in the material and methods section. Briefly, a synthetic coding genome was generated by concatenating the different coding sequences allowing the counting of the occurrence of a given K-mer ([Fig 1B](#ppat.1008718.g001){ref-type="fig"}, n obs (K-mer)). Each synthetic coding genome has been randomly shuffled a thousand times. The expected count is calculated as the average of the occurrences of this K-mer over the thousand iterations ([Fig 1B](#ppat.1008718.g001){ref-type="fig"}, n exp (K-mer)). A negative K-mer ratio indicates depletion of that K-mer. The observed vs expected ratio of the NTC K-mer will be compared to those of the NNTCNN and TCN K-mers. Similarly, the observed vs expected ratio of the NNGANN K-mer will be compared to those of the GAN and NGA K-mers. Of note, for the sake of clarity and simplicity, we have chosen to stick with a DNA genetic code throughout the manuscript. The reader will read a T as a U in the context of RNA viruses.

![Definition and estimation method of the A3 footprint.\
A. A3-induced cytidine deamination followed by viral replication leads to C to T mutations (in red). Most of the A3 enzymes favor deamination in a 5'TC context. The TC dinucleotide motif is depicted in three possible codon contexts on both coding and template strand. Depending on the position of the mutated C, the C to T transition can be synonymous (S) or non-synonymous (NS). Proportion of S and NS mutations is reported when the two types of mutation can be produced. Because synonymous mutations are more likely to be retained, the A3 footprint can be defined as the depletion of the NTC and/or NNGANN codons. B. Depletion or enrichment of a given K-mer (e.g. NTC) is calculated as the log2 ratio of the observed occurrence of that K-mer (n obs) divided by its expected occurrence (n exp). For each human virus, its coding sequences (colored arrows) are concatenated to generate a synthetic coding genome from which we obtain the n obs of a given K-mer. The synthetic coding genome is then shuffled a thousand times and the n exp is calculated as the average count for that K-mer.](ppat.1008718.g001){#ppat.1008718.g001}

Secondly, and because A3G favors deamination of cytidine when preceded by another cytidine, we have chosen to look for the under-representation of the 5'CC motif. Following the same rationale, A3G-footprinted viruses should display to a stronger depletion of NCC codons compared to CCN or NNCCNN motifs (or a depletion of NNGGNN motifs versus the GNN and NGG motifs) ([S1A Fig](#ppat.1008718.s001){ref-type="supplementary-material"}). The NCC ratio will be compared to those of the NNCCNN and CCN K-mers. Similarly, the NNGGNN ratio will be compared to those of the GGN and NGG K-mers.

An A3 footprint is detected in viruses known to induce A3 expression {#sec004}
--------------------------------------------------------------------

Given that the BK polyomavirus has recently been demonstrated to induce A3B expression and that it was depleted in 5'TC motifs \[[@ppat.1008718.ref017]\], we considered this virus as a positive control to validate our approach. [Fig 2A](#ppat.1008718.g002){ref-type="fig"} shows a strong depletion of the NTC motif. On the contrary, the dinucleotide 5'TC in the context of the NNTCNN and TCN K-mers are neither over- nor under-represented. The significant differences between the NTC ratio and the TCN (or NNTCNN) ratios reveal that the frequency of the TC motif is dependent on its position within a codon. It suggests that NTC depletion can be tolerated because of the degeneration of the genetic code. Importantly, the absence of NNTCNN and TCN depletion infers that this virus is still vulnerable to A3 restriction because deamination of those cytidines would lead to changes in the amino acid sequence. [Fig 2B](#ppat.1008718.g002){ref-type="fig"} highlights the fact that NTC depletion is genome-wide and can be observed in each gene. Similarly, the 5'GA motif is significantly less abundant in the NNGANN context than in the GAN or NGA codons. The 5'GA depletion is also genome-wide ([Fig 2B](#ppat.1008718.g002){ref-type="fig"}). We read these observations as the consequence of an A3 activity acting on both coding and template strands.

![Evidence of an A3 footprint in human polyomaviruses.\
The observed/expected ratios of TC dinucleotide at various codon positions and on both strand (i.e. NNTCNN, TCN, NTC, GAN, NGA and NNGANN) were calculated for BK polyomavirus (panels A-B), JC polyomavirus (panels C-D) and Merkel cell polyomavirus (panel E-F). For the dot plots, each point stands for a unique full-length viral genome. Median and quartile are depicted by a boxplot. P-values were calculated by Student's unpaired, two-tailed t-test (NS for not significant, \* p\< 0.05, \*\* p\< 0.01, \*\*\* p\< 0.001). Panels B, D and F illustrate NTC and NNGANN ratios for the different viral coding sequences. A colored scale with increasing shades of blue indicating depletion and increasing shades of red indicating enrichment. Replication origin is illustrated by a black dot and gene transcriptional orientation is symbolized by black arrows.](ppat.1008718.g002){#ppat.1008718.g002}

Extending our analysis to other polyomaviruses shows that both JC polyomavirus and Merkel cell polyomavirus bear an A3 footprint; footprint that is also genome-wide and present on both strands ([Fig 2C--2F](#ppat.1008718.g002){ref-type="fig"}). The magnitude of the A3 footprint appears lighter on the Merkel cell polyomavirus. Analysis of a larger number of polyomavirus species shows a stronger NTC depletion in *beta-polyomaviridae* by comparison to *alpha-polyomaviridae* ([S2 Fig](#ppat.1008718.s002){ref-type="supplementary-material"}). The *delta-polyomaviridae* are affected by an A3 footprint of variable intensity depending on the species considered ([S2 Fig](#ppat.1008718.s002){ref-type="supplementary-material"}).

The A3 footprint is limited to viruses infecting hosts endowed with A3 genes {#sec005}
----------------------------------------------------------------------------

We showed that our approach sensitively detects an NTC depletion in viruses known to promote A3 expression. We then wondered to what extent this depletion is widespread among viruses. We therefore downloaded genomic sequences of 33,400 human, 1,397 non-human primate, 9,160 avian, and 570 fish viruses and calculated NNTCNN, TCN and NTC ratios ([Fig 3B](#ppat.1008718.g003){ref-type="fig"}). With NNTCNN, TCN and NTC median ratios close to zero, most of the sequences are not A3-footprinted ([Fig 3B](#ppat.1008718.g003){ref-type="fig"}, box plots). However, the distribution of the NTC ratios is bimodal in human and non-human primate viruses with a subpopulation of sequences strongly depleted for the NTC codon ([Fig 3B](#ppat.1008718.g003){ref-type="fig"}, arrows and 4A red part of the distribution plot). Crucially, such footprinted subpopulation is not detected in avian or fish viruses ([Fig 3B](#ppat.1008718.g003){ref-type="fig"}). Hence, the absence of a detectable A3 footprint in avian and fish viral sequences is consistent with the restriction of the A3 genes family to the mammalian class \[[@ppat.1008718.ref037]\]. It is worth mentioning that each Baltimore's group is represented in the human, non-human primate, avian and fish viral sequence data sets, albeit in different proportions ([Fig 3A](#ppat.1008718.g003){ref-type="fig"}).

![A sub-population of Human and non-human primate viruses is depleted in NTC codon.\
Four datasets including Human viruses (n = 33,400), non-human primate viruses (n = 1,397), avian viruses (n = 9,160) and fish viruses (n = 570) have been analyzed for their observed/expected K-mer ratios. A. The composition of each data set regarding the breakdown into viral groups is illustrated by pie charts. B. The observed/expected ratios of TC dinucleotide at various codon positions for Human, non-human primate, bird and fish viruses are illustrated by dot plots (one point represents one unique viral sequence). C. K-mers are grouped and colored according to their capacity to encode a common amino-acid (in red for NTT/C, in yellow for NCC/G/T/A, in orange for NGT/C, in blue for NAC/T and in green for NAA/G).](ppat.1008718.g003){#ppat.1008718.g003}

Due to the redundancy of the genetic code, different codons can encode for the same amino acid. The third position of the codons is highly reiterated (redundant) and allows synonymous substitutions. This is notably the case for the NTC and NTT codons where the C or T at the third position are perfectly interchangeable ([Fig 3C](#ppat.1008718.g003){ref-type="fig"}, colored in red). While we observe a subpopulation of sequences depleted for NTC, such depletion is not observed for NTT. Hence, the NTC depletion cannot simply be explained by the under-representation of an amino acid. The pair NTC/NTT is not the only interchangeable pair. The NAA/NAG, NAC/NAT, NGT/NGC duos and the NCC/NCT/NCG/NCA quartet are also interchangeable. The distribution of NTC ratios remains the sole being bimodal with a subpopulation of strongly depleted sequences. The general NCG depletion (monomodal distribution with a median significantly less than zero) is the result of the well characterized CG dinucleotide under-representation in viral genomes \[[@ppat.1008718.ref038]\]. This depletion is shared in all viral datasets while the NTC depletion is specific to a subpopulation of human and non-human primate viral sequences.

By breaking down the human viruses into their respective Baltimore's group ([S3 Fig](#ppat.1008718.s003){ref-type="supplementary-material"}), we observed that NTC depletion is not present in reverse transcribing nor in negative sense single strand RNA viruses. A mild general depletion is present in double strand RNA viruses. Importantly, a strong general depletion can be observed in double strand DNA viruses. Finally, in single strand DNA and positive sense single strand RNA viruses, certain specific viral sequences appear also significantly depleted. We also observed a mild general NCC depletion in single strand DNA and double strand RNA viruses, justifying further investigation for a possible A3G-induced footprint ([S1 Fig](#ppat.1008718.s001){ref-type="supplementary-material"}). No NCC depletion is observed in double strand DNA, single strand RNA nor in reverse transcribing viruses.

Screening for human viruses' genomes marked by an A3 footprint {#sec006}
--------------------------------------------------------------

In order to identify A3-footprinted viruses, we detailed the NTC and NNGANN ratios for 870 human viral species ([Fig 4A](#ppat.1008718.g004){ref-type="fig"}). We observed that the NTC and NNGANN distributions are bimodal with a subpopulation of depleted sequences in each case. We consider a viral species as footprinted by A3s when its NTC or NNGANN median ratio is inferior to the population median by at least two times the standard deviation. Hence, about 17% of the viral species are depleted for NTC (143 species over 870) and about 16% are depleted for NNGANN motifs (136 species over 870). In total, 175 species (22%) present an A3 footprint on either one or both strands. This subgroup is essentially composed by double-stranded DNA viruses with numerous *alpha-*, *beta-* and *gamma- papillomaviridae* (αPV, βPV and γPV) but also *beta-polyomaviridae* (BKPyV, JCPyV, KIPyV, WUPyV and HPyV9) and the delta-polyomavirus MWPyV ([Fig 4B](#ppat.1008718.g004){ref-type="fig"}). These viruses show a strong depletion for both the NTC and NNGANN motifs by comparison to NNTCNN/TCN and GAN/NGA ([Fig 4B](#ppat.1008718.g004){ref-type="fig"}). Of note, NTC depletion generally goes with a mild to a significative NTT enrichment ([S4 Fig](#ppat.1008718.s004){ref-type="supplementary-material"}). In the strongly NTC-depleted viruses HPV16, HPV18 and HPV31, a TC depletion is also observed in the non-coding region of the genome regardless of the analyzed motif ([S5 Fig](#ppat.1008718.s005){ref-type="supplementary-material"}). To recapitulate, the A3 footprint on the *papillomaviridae* and *polyomaviridae* is genome-wide and on both strands ([Fig 2](#ppat.1008718.g002){ref-type="fig"}, [Fig 4B](#ppat.1008718.g004){ref-type="fig"} and [S6 Fig](#ppat.1008718.s006){ref-type="supplementary-material"}). Importantly, we also identified the single-stranded DNA virus erythroparvovirus B19 and the single-stranded RNA virus HKU1 beta-coronavirus as strongly footprinted by A3s ([Fig 4B](#ppat.1008718.g004){ref-type="fig"}, highlighted). We will further detail the A3 footprint of these viruses in the following sections.

![Search for the A3-footprinted human viruses.\
A. The NTC and NNGANN observed/expected ratios for 33,400 human viruses' genomes (from 870 unique species) were calculated, grouped by species and colored according to the Baltimore classification. Each point represents a unique viral genome. Abundance distribution is depicted by a histogram on the right-hand side of the panel. Viral species with an NTC or NNGANN ratio below two times the standard deviation (dotted grey line) from the population median (red line) are the putative A3-footprinted viruses. B. The observed/expected ratios of TC dinucleotide at various codon positions and on both strands (i.e. NNTCNN, TCN, NTC, GAN, NGA and NNGANN) were calculated for the putative A3-footprinted viral species and depicted by a heatmap. A colored scale with increasing shades of blue indicating depletion and increasing shades of red indicating enrichment. P-values were calculated by Student's unpaired, two-tailed t-test (NS for not significant, \* p\< 0.05, \*\* p\< 0.01, \*\*\* p\< 0.001). (PV stands for papillomavirus, PyV for polyomavirus).](ppat.1008718.g004){#ppat.1008718.g004}

In order to specifically look for A3G-footprinted viruses, we calculated the NCC and NNGGNN ratios for 870 human viral species ([S1B Fig](#ppat.1008718.s001){ref-type="supplementary-material"}). We observed that the NCC and NNGGNN ratios are mostly narrowly distributed around the zero value. Viruses depleted for NCC are generally single stranded DNA viruses ([S1B Fig](#ppat.1008718.s001){ref-type="supplementary-material"}). However, in many of them we observed a concomitant depletion of the NNCCNN motif casting doubts on the causal link between the observed NCC depletion and A3G editing ([S1C Fig](#ppat.1008718.s001){ref-type="supplementary-material"}).

B19 erythroparvovirus genome bears a strong A3 footprint {#sec007}
--------------------------------------------------------

One of the most A3-footprinted virus is the B19 erythroparvovirus. Among the *parvoviridae* family, the TC ratio analysis showed a strong NTC depletion for erythroparvovirus B19 and to a lesser extent for parvovirus 4 and bocavirus 4 ([Fig 5A](#ppat.1008718.g005){ref-type="fig"}). We also observed a significant depletion of the NNGANN K-mer for each autonomous parvovirus (erythroparvovirus, parvovirus 4 and bocaparvovirus 1, 2, 3 and 4) ([Fig 5A](#ppat.1008718.g005){ref-type="fig"}). Thus, autonomous parvoviruses appear to be footprinted either on both strands as for the erythroparvovirus, the parvovirus 4 and bocaparvovirus 4 or only on the template strand for the bocaparvovirus 1, 2 and 3. It is interesting to note that the AAV-1 (adeno-associated dependoparvovirus 1) shows a totally different pattern with even a slight enrichment in NTC codons. This dependoparvovirus is not footprinted by the A3s.

![Intensive A3 footprint on both strands of the B19 Erythroparvovirus genome.\
A. The observed/expected ratios of TC dinucleotide at various codon positions for the B19 Erythroparvovirus were compared to those of the other human members of the *parvoviridae* family and depicted by a heatmap. A colored scale with increasing shades of blue indicating depletion and increasing shades of red indicating enrichment. P-values were calculated by Student's unpaired, two-tailed t-test (NS for not significant, \* p\< 0.05, \*\* p\< 0.01, \*\*\* p\< 0.001). B. Coding sequences (NS1, 7.5k, VP1, X, VP2 and 11k) from 18 full-length B19 erythroparvirus were depicted by grey lines overlaid by red marks to symbolize NTC and green marks to position NTT codons. Zoom-in detailed a 60 bp-long sequence from the NS1 and 7.5k genes (from nucleotide 1723 to 1783). A second zoom-in detailed a 15 bp-long sequence from the VP1-VP2 genes (from nucleotide 3973 to 3987).](ppat.1008718.g005){#ppat.1008718.g005}

Detailed analysis of the erythroparvovirus B19 sequences shows a nearly complete NTC cleansing along the whole genome ([Fig 5B](#ppat.1008718.g005){ref-type="fig"}, red marks). On the contrary, NTT codons are distributed all along ([Fig 5B](#ppat.1008718.g005){ref-type="fig"}, green marks). Some NTC codons remain present in a short, discrete section of the NS1 gene. This region also encodes for the 7.5k protein in another coding frame. Hence, the remaining TC motifs in the NS1 gene are TCN codon context in the 7.5k protein gene. The mutation of those TCs would introduce non-synonymous mutation in the 7.5k protein. This probably explains the conservation of those TC motifs.

Moreover, among the 18 sequences illustrated in [Fig 5B](#ppat.1008718.g005){ref-type="fig"}, some locations harbor a mix of NTC and NTT codons, suggesting that C to T transition is still an active process (zoom for VP1-VP2 sequence). An A3 footprint can also be observed in the template strand as shown by the NNGANN depletion ([Fig 5A](#ppat.1008718.g005){ref-type="fig"} and [S7 Fig](#ppat.1008718.s007){ref-type="supplementary-material"}). These observations show that the B19 erythroparvovirus is submitted to an ongoing and strong A3 selection pressure acting on both strands of the virus.

Human endemic coronaviruses but not zoonotic coronaviruses carry an A3 footprint {#sec008}
--------------------------------------------------------------------------------

By comparing the NTC ratio to the NNTCNN and TCN ratios, we observed a common NTC depletion in the NL63, 229E, HKU1 and OC43 coronaviruses; the HKU1-CoV being the most strongly deleted in NTC codons ([Fig 6](#ppat.1008718.g006){ref-type="fig"}). In coronaviruses, all viral genes are encoded by the positive strand. In other words, the coding strand of each gene is on the positive strand. Therefore, the depletion of NTC codons is indicative of an A3 activity on the positive strand. These observations corroborate the *in vitro* detection of a soft rate of A3C, A3F and A3H editing on the NL63 genome and the NNU/NNC codon bias previously reported for the HKU1 coronavirus \[[@ppat.1008718.ref019],[@ppat.1008718.ref034]\].

![A3 footprint on endemic but not on zoonotic coronaviruses.\
The observed/expected ratios of TC dinucleotide at various codon positions were calculated for endemic human coronaviruses (229E, NL63, OC43 and HKU1) and compared to those of zoonotic coronaviruses (MERS-CoV, SARS-CoV-1 and SARS-CoV-2) and their ancestors (camel-MERS and bat-SARS). A colored scale with increasing shades of blue indicating depletion and increasing shades of red indicating enrichment. P-values were calculated by Student's unpaired, two-tailed t-test (NS for not significant, \* p\< 0.05, \*\* p\< 0.01, \*\*\* p\< 0.001).](ppat.1008718.g006){#ppat.1008718.g006}

Next, we investigated the presence of an A3 footprint on the template strand (corresponding to the negative strand in coronaviruses) by comparing the 5'GA ratios in different codon contexts. However, we did not observe a progressive depletion of the GA motif (i.e. NNGANN ratio \< NGA ratio ≤ GAN ratio) which would be expected in the presence of a GA to AA mutational pressure. For that reason, we cannot rule on the presence of an A3 footprint on the negative strand ([Fig 6](#ppat.1008718.g006){ref-type="fig"}).

Finally, unlike endemic viruses, the zoonotic viruses MERS-CoV, SARS-CoV-1 and SARS-CoV-2 and their animal ancestors camel-MERS, bat-MERS and bat-SARS are not depleted for NTC codons ([Fig 6](#ppat.1008718.g006){ref-type="fig"}).

Looking for an A3 footprint at the gene level {#sec009}
---------------------------------------------

Since a non-random distribution for A3 mutations has been reported for some viruses, we then looked for spatially circumscribed A3 footprint; i.e. A3 footprint limited to certain viral genes To limit our screening on genes which are depleted compared to the whole genome, we subtracted to the genic K-mer ratio, the corresponding genomic K-mer ratio to define the differential ratio for NTC and NNGANN K-mers ([Fig 7A](#ppat.1008718.g007){ref-type="fig"}). In other words, we looked for viruses harboring local A3 footprint amongst an otherwise non-footprinted genome. Thus, differences between genic and genomic K-mer ratios were calculated for 252,766 viral genes. [Fig 7B](#ppat.1008718.g007){ref-type="fig"} shows the viral genes having an NTC (or NNGANN) differential ratio inferior to the median by at least two times the standard deviation. Thus, we identified many genes being footprinted by A3 among otherwise unaffected viral genomes. Most of these genes belongs to two families of double-stranded DNA viruses; i.e. *herpesviridae* (HHV-1, 2, 3, 4, 5 and 8) and *adenoviridae* (AdV A, B, C, D, E and F). We also observed A3-footprinted genes in the reverse transcribing HBV, HIV-1 and HTLV-1. In order to better shed light on the possible mechanisms responsible for such editing, we position the identified genes along the corresponding viral genomes and detailed these analyses in the following sections.

![Search for an A3 footprint at the gene level.\
A. Alongside the observed/expected K-mer ratios calculated from the synthetic coding genomes (named genomic K-mer ratios), K-mer ratios were also computed for each viral coding sequence individually (named genic K-mer ratios). Differential ratio is defined as the subtraction of genic K-mer ratio to the corresponding genomic K-mer ratio. B. List of the putative A3-footprinted viral genes and belonging to an otherwise non-depleted viral genome (having at least five reported sequences).](ppat.1008718.g007){#ppat.1008718.g007}

An equivalent analysis was performed to report a local A3G footprint amongst an otherwise non-footprinted genome. NCC and NNGGNN-depleted genes are listed in [S1D Fig](#ppat.1008718.s001){ref-type="supplementary-material"}. Similarly to what has been observed at the genome level, many of the NCC-depleted genes are also depleted for the NNCCNN motif making difficult to ascribe the observed NCC depletion to the sole A3G editing activity.

Identification of an A3 footprint at the replication origins of adenoviruses and EBV {#sec010}
------------------------------------------------------------------------------------

Adenoviruses A and B present a strong NTC depletion for the E1A and E4 genes ([Fig 8A](#ppat.1008718.g008){ref-type="fig"}); genes localized at both ends of the linear genome ([S8 Fig](#ppat.1008718.s008){ref-type="supplementary-material"}). The same trend can be observed in Adenovirus C, D and E, although to a lesser extent ([S9 Fig](#ppat.1008718.s009){ref-type="supplementary-material"}). Importantly, these E1A and E4 genes are being strongly depleted for NTC but not for the NNGANN motif ([Fig 8B](#ppat.1008718.g008){ref-type="fig"}). In other words, these two genes are A3-footprinted on their coding strand only. Due to the relative position of those genes and the strand-displacement strategy used for genome replication, we propose a model where A3 editing would occur specifically during the initiation of genome replication on the displaced strands ([Fig 8C](#ppat.1008718.g008){ref-type="fig"}). Indeed, at the beginning of DNA replication, the displaced strand corresponds to the coding strand of E1A at one end of the linear genome and to the coding strand of E4 at the other extremity. One might also notice an NNGANN depletion for most of the L5 genes ([Fig 8B](#ppat.1008718.g008){ref-type="fig"} and [S9 Fig](#ppat.1008718.s009){ref-type="supplementary-material"}). Considering the position and orientation of that gene, such footprint might also reflect an A3 activity on the displaced strand ([Fig 8C](#ppat.1008718.g008){ref-type="fig"}).

![A3 footprint at the genomic ends of adenoviruses.\
NTC observed/expected ratios (panel A) and NNGANN observed/expected ratios (panel B) were calculated for the different genes of the Adenovirus A and B (each point represents a unique coding sequence). C. Proposed model for A3-editing activity on the adenovirus genome. Genes are represented by black arrows. A3-favored NTC sequence is represented in red and the NTT edited product in green.](ppat.1008718.g008){#ppat.1008718.g008}

Among the 172 EBV genes, only 12 are significantly depleted for NTC ([Fig 7B](#ppat.1008718.g007){ref-type="fig"}). Interestingly, the five most depleted are localized around the lytic origins of replication. BHLF1 and BHRF1 are localized on both sides of the first lytic origin of replication and LF3, RPMS1 and A73 are on both sides of the second lytic origin of replication ([Fig 9B](#ppat.1008718.g009){ref-type="fig"}). Similar to the adenoviruses, this local A3 footprint is very much strand-specific and present on the lagging strands of the replication forks surrounding the lytic origins ([Fig 9B](#ppat.1008718.g009){ref-type="fig"}). Thus, the EBV specific footprint is pointing toward A3 editing during the beginning of replication at the lytic origins. We summarize these observations by a scheme in [Fig 9C](#ppat.1008718.g009){ref-type="fig"}.

![A3 footprint at the lytic replication origins of EBV.\
A. NTC observed/expected ratios were calculated for the different genes of EBV (each point represents a unique coding sequence) and the five most A3-footprinted genes were highlighted and positioned on the EBV genome map. B. Zoom-in detailing the NTC ratios of the genes surrounding the Ori-Lyt (lytic origin of replication) of EBV. A colored scale with increasing shades of blue indicating NTC depletion and increasing shades of red indicating NTC enrichment. C. Proposed model for A3-editing activity favoring the lagging strand at the EBV lytic origin of replication. A3-favored NTC sequence is represented in red and the NTT edited product in green.](ppat.1008718.g009){#ppat.1008718.g009}

The footprint on the HTLV-1, HBV, HIV-1 and HIV-2 genomes fits with editing during reverse transcription {#sec011}
--------------------------------------------------------------------------------------------------------

We observed that the HBZ gene of the HTLV-1 virus is depleted for NTC codons ([Fig 7B](#ppat.1008718.g007){ref-type="fig"}). Because HBZ is an antisense transcript, its coding strand corresponds to the genomic negative strand. Hence, the NTC depletion of the HBZ gene is indicative of an A3 editing activity on the negative strand ([Fig 10A and 10B](#ppat.1008718.g010){ref-type="fig"}). We then wondered whether such A3 footprint was restricted to the HBZ coding region or rather extend further. We observed that the coding sequences of the sense transcripts Gag, Pro, Pol and Tax are depleted for the NNGANN motif ([Fig 10A and 10B](#ppat.1008718.g010){ref-type="fig"}). These observations suggest that A3s left an evolutionary footprint on the HTLV-1 virus through editing during reverse transcription.

![A3 footprint on the negative strand of HTLV-1 and HBV.\
A. NTC and NNGANN observed/expected ratios were calculated for the different genes of HTLV-1. B. Each gene specific NTC and NNGANN ratio median values were reported on HTLV-1 genome map by a colored scale. C. NTC and NNGANN observed/expected ratios were calculated for the different genes of HBV. D. Each gene specific NTC and NNGANN ratio median values were reported on HBV genome map by a colored scale.](ppat.1008718.g010){#ppat.1008718.g010}

Depletion for the NNGANN motif has been observed for the C, preC/HBeAg coding sequences of HBV ([Fig 7B](#ppat.1008718.g007){ref-type="fig"}). These observations support the involvement of an A3 editing activity on the DNA negative strand during the reverse transcription process. However, it is interesting to report that nor the Pol neither the S and X coding sequences are being footprinted ([Fig 10C and 10D](#ppat.1008718.g010){ref-type="fig"})

Conflicting data were reported concerning the presence of an A3 evolutionary footprint on the HIV-1 genome \[[@ppat.1008718.ref031],[@ppat.1008718.ref032]\]. [Fig 11](#ppat.1008718.g011){ref-type="fig"} reports ratios of the TC and GA-containing K-mers for the HIV-1, HIV-2 and SIV genomes. The HIV-1 genomes were spread out into their respecting groups (M, N, O) and subtypes (group M subtypes A, B, C, D and E). No NTC depletion was observed on the HIV-1, HIV-2 and SIV genomes ([Fig 11](#ppat.1008718.g011){ref-type="fig"}). We concluded that A3s did not leave a footprint on the plus strand. Importantly, a mild but consistent NNGANN depletion was observed in HIV-1, HIV-2 and SIV genomes, depletion compatible with A3-editing during reverse transcription.

![A3 footprint on the negative strand of HIV-1, HIV-2 and SIV.\
The observed/expected ratios of TC dinucleotide at various codon positions and on both strand (i.e. NNTCNN, TCN, NTC, GAN, NGA and NNGANN) were calculated for the genomes of HIV-1 (distributed into their respective groups and subtypes, panels A to G), HIV-2 (panel H) and SIV (panel I). Each point stands for a unique full-length viral genome. Median and quartile are depicted by a boxplot. P-values were calculated by Student's unpaired, two-tailed t-test (NS for not significant, \* p\< 0.05, \*\* p\< 0.01, \*\*\* p\< 0.001).](ppat.1008718.g011){#ppat.1008718.g011}

Search for AID or APOBEC1-footprinted viruses {#sec012}
---------------------------------------------

The APOBEC family of genes also counts the AID (or AICDA), APOBEC1, APOBEC2 and APOBEC4 genes. AID is critical for somatic hypermutation and class switch recombination by editing the immunoglobulin loci in B cells \[[@ppat.1008718.ref039]\]. APOBEC1 plays an important role in lipid metabolism by editing the apolipoprotein B pre-mRNA \[[@ppat.1008718.ref040],[@ppat.1008718.ref041]\]. Importantly, APOBEC1 and AID appear also to participate to the restriction of viruses and retroelements \[[@ppat.1008718.ref001],[@ppat.1008718.ref042]\]. Evidence for AID and APOBEC1 evolutionary footprints were investigated by looking for the depletion of their favored motifs, respectively WRC for AID \[[@ppat.1008718.ref043]\] and WCW for APOBEC1 \[[@ppat.1008718.ref044]\].

The distributions of the WRC and NNGYWN ratios do not point towards viruses significantly footprinted by AID at the whole genome level ([S10B Fig](#ppat.1008718.s010){ref-type="supplementary-material"}). Nevertheless, putatively AID-footprinted genes were identified in several double strand DNA viruses, notably the B-cell-infecting virus EBV ([S10C Fig](#ppat.1008718.s010){ref-type="supplementary-material"}).

The distributions of the NWCWNN and NWGWNN ratios show evidence of genome-wide footprinted viruses ([S11B Fig](#ppat.1008718.s011){ref-type="supplementary-material"}). However, it is not possible to disentangle the APOBEC1 footprint from the APOBEC3 footprint as the 6-mers NWCWNN contains the 3-mers NTC. The putatively APOBEC1-footprinted viruses are those that also bear the putative APOBEC3 footprint ([Fig 4B](#ppat.1008718.g004){ref-type="fig"} and [S11C Fig](#ppat.1008718.s011){ref-type="supplementary-material"}).

Of note, APOBEC2 and APOBEC4-favored motifs have not been described so far.

Discussion {#sec013}
==========

In this study, we investigated the distribution of the A3 footprint along a large set of 33,400 human virus complete genomes. We first observed that no less than 22% of all referenced human viral species have a genome-wide A3 footprint. Among these, we mainly identified viruses from the *papillomaviridae*, *polyomaviridae*, *coronaviridae* and autonomous *parvoviridae* families. In addition to this category of viruses targeted over their entire sequence, we have identified viruses which have an A3 footprint spatially limited to a short section of their genome. This is notably the case for certain *herpesviridae* and *adenoviridae* where the A3 footprint is localized on genomic sequences used to initiate replication of viral DNA.

Our study is in line with previous publications reporting the presence of an A3 footprint on *papillomaviridae* \[[@ppat.1008718.ref029]\] and on the BK polyomavirus \[[@ppat.1008718.ref017]\]. Above all and because we analyzed all currently annotated human viruses with the same approach, we can compare the magnitude of the A3 selection pressure between different viral families. Thus, we show that the *papillomaviridae* and the *polyomaviridae* families are those whose footprint is most intensive ([Fig 4A](#ppat.1008718.g004){ref-type="fig"}). Those viruses have evolved to thrive under an ongoing and strong A3 selection pressure. The strong NTC depletion reduces exposure of the viral genome to the introduction of uracil and consequently to the base excision repair-mediated DNA degradation. Importantly, not only do these viruses tolerate such pressure, but they even actively promote the expression of certain A3 proteins. Indeed, high risk α-HPVs have been shown to trigger and stabilize A3A and A3B via their oncoproteins E6 and E7 \[[@ppat.1008718.ref016],[@ppat.1008718.ref045]--[@ppat.1008718.ref047]\]. Likewise, it has recently been shown that BK and JC β-PyV upregulate A3B through their large T antigen \[[@ppat.1008718.ref017],[@ppat.1008718.ref048]\]. In both the α-HPVs and β-PyVs, the induced A3 proteins are enzymatically active and therefore capable of deamination \[[@ppat.1008718.ref017],[@ppat.1008718.ref049]\]. The selective advantage which would provide a sustained expression of A3A and/or A3B proteins is still debated. On the one hand, A3A has been shown to restrict HPV *in vitro* \[[@ppat.1008718.ref045]\]. Those viruses are still susceptible to A3 restriction. Indeed, deamination of the remaining TC motifs are most of the time non-synonymous. On the other hand, the deaminase activity could positively impact viral fitness by participating to the genetic diversification of the virus or even by protecting the host cell against the reactivation of retroelements \[[@ppat.1008718.ref050],[@ppat.1008718.ref051]\]. We speculate that the error rate of the host DNA polymerase could be too low for viruses with such small DNA genome, hence requiring the A3 editing activity to drive their evolution. Within the *polyomaviridae* family, the magnitude of the A3 footprint differs significantly between species; species of the *betapolyomavirus* genus appearing to be the most strongly footprinted ([S2 Fig](#ppat.1008718.s002){ref-type="supplementary-material"}). Such differences could find their origin in the capacity of the large T Ag at inducing the A3 proteins. To draw a parallel with the *alpha-papillomaviridae*, E6 from high-risk α-HPVs were found to be more potent at inducing A3B than those of low-risk strains \[[@ppat.1008718.ref049]\]. Besides, the cell type hosting the virus can also influence the level of A3 expression. The difference in tissue tropism between the *alpha-* and *beta-papillomaviridae* has been proposed to explain the stronger footprint on the former \[[@ppat.1008718.ref029]\]. The full spectrum of tissue and cell tropism has not been clearly established for the *polyomaviridae*, making this type of correlative analysis tricky. Our analysis also shows that the A3 footprint is present on both strands of the *papillomaviridae* and *polyomaviriridae* genomes. This is compatible with an editing activity during viral DNA replication.

Among the *parvoviridae* family, the erythroparvovirus B19 exhibits an intensive footprint on both strands of its genome, the bocaparvoviruses being mainly footprinted on the negative strand and the dependoparvovirus adeno-associated virus-1 showing no evidence of A3 selection pressure. These dissimilarities might be explained by differences at the replicative and packaging levels. Thus, the *parvoviridae* family consists of viruses that package a single copy of their short linear single-stranded DNA genome into preformed capsids. The packaging takes place in the nucleus of the infected cell. While most can encapsidate DNA strands of either polarity with equal efficiency, some family members, predominantly package negative strand genome. In the case of the erythroparvovirus, there is an equivalent amount of positive and negative genome that is produced during replication and subsequently encapsidated (reviewed in \[[@ppat.1008718.ref052]\]). For *bocaparvoviridae*, the replication produces 90% of negative ssDNA \[[@ppat.1008718.ref053]\]. Such difference could explain the location of the A3 footprint in the negative strand of the *bocaparvoviridae*. Thus, we propose that A3 editing activity takes place inside the nascent virions of the autonomous *parvoviridae*.

Our screening also reported the *coronaviridae* as A3-footprinted. The canonical substrate for the A3 proteins is single stranded DNA and until recently, the viruses identified as being restricted by the A3 deaminase activity were either DNA viruses or viruses having a DNA intermediate (i.e. reverse transcribing viruses). However, recent reports demonstrated that A3A and A3G can deaminate ribocytidine within a single stranded RNA molecule \[[@ppat.1008718.ref054]--[@ppat.1008718.ref056]\]. *In vivo*, A3 mutational signature has been reported in the positive single strand RNA Rubella virus \[[@ppat.1008718.ref057]\]. Importantly, Milewska and colleagues demonstrated that cytoplasmic A3s can restrict the NL63 coronavirus *in vitro* \[[@ppat.1008718.ref019]\]. The A3-mediated restriction of the HCoV-NL63 appears to be both deaminase-dependent and independent. A3 restriction did not cause hypermutation on the viral genome, but C to T and G to A point mutations were observed in HCoV-NL63 viruses passaged in A3-expressing cells but not in wild-type cells. It is a matter of debate whether the hypermutated genomes could not be retrieved because of the high fitness cost of such mutations or because the A3 are less processive on coronaviral RNA. Additionally, A3 proteins have been shown to interact with the nucleoproteins of the HCoV-229E, HCoV-NL63 and SARS-CoV-1 viruses \[[@ppat.1008718.ref019],[@ppat.1008718.ref058]\]. Finally, a recent report demonstrates the presence of APOBEC and ADAR editing on the SARS-CoV-2 transcriptome \[[@ppat.1008718.ref059]\]. Thus, knowing that A3s can bind the nucleoprotein and that A3 footprint is present on the positive strand of the viral genome, we suggest that A3 editing occurs on the packaged genome. Two *beta-coronaviridae* are endemic to humans (HCoV-OC43 and HCoV-HKU1), they are widespread, have been circulating in human for at least several decades and may cause 10 to 15% of common colds (review in \[[@ppat.1008718.ref060]\]). Both have an A3 footprint on the positive strand. In comparison, no evidence of footprint was observed on the zoonotic *beta-coronaviridae* SARS-CoV-1, MERS-CoV or SARS-CoV-2. The absence of an evolutionary footprint on SARS-CoV-1 and MERS-CoV could find its explanation in the relative low number of infected individuals and the short duration of viral circulation. According to the World Health Organization, SARS-CoV-1 infected about 8.000 people over a period of few months and have been declared eradicated in May 2004. The MERS-CoV infected so far less than 3.000 people by causing episodic outbreaks in the Middle East. The figures for the SARS-CoV-2 are radically different with more than 5 million confirmed cases as of May 2020. In that respect, it will be interesting to track the evolution of the pandemic SARS-CoV-2 regarding a possible introduction of an A3 footprint through its interhuman transmissions. It is worth reiterating that no footprint was detected on the SARS bat isolates, although the bat A3 locus is the largest and most diverse known repertoire of A3 genes in mammals \[[@ppat.1008718.ref061]\]. Perhaps SARS-like viruses possess a yet unknown and unique A3 inhibiting mechanism. Interestingly, the SARS-CoV-2 genome contains a novel ORF, called ORF10. ORF10 encodes a protein that has been demonstrated to interact with the CUL2 complex \[[@ppat.1008718.ref062]\]. This interaction is reminiscent of the interaction between the Vif of BIV (bovine immunodeficiency virus) and CUL2 \[[@ppat.1008718.ref063]\]. One could speculate that ORF10 could play a Vif-like role in bat and also in Human. Also, a shorter version of SARS-CoV-2 ORF10 is present in all SARS-like viruses \[[@ppat.1008718.ref064]\]. This could explain why the SARS-like viruses are not A3-footprinted.

In addition to this category of viruses that are footprinted on their entire sequence, we identified viruses that show an A3 footprint only on a very limited section of their genome. This is notably the case for the *gamma-herpesviridae* EBV and *adenoviridae*. The A3 footprint on EBV is spatially limited to the lagging strands around the lytic replication origins. Interestingly, both EBV and KSHV were recently demonstrated to encode viral proteins capable of inhibiting A3B activity \[[@ppat.1008718.ref028],[@ppat.1008718.ref065]\]. Those viral proteins (EBV BORF2 and KSHV ORF61) are both the large subunit of the ribonucleotide reductase, expressed during lytic replication and providing the precursors necessary for viral DNA synthesis. We speculate that their expression could avoid the extension of the A3-editing further along the viral genome. Of course, these viral proteins inhibiting A3B may not be the sole actors protecting the viral genome. The coating of the viral DNA by the major DNA binding protein (DBP), the compartmentalization of the viral DNA replication \[[@ppat.1008718.ref066]\] and the switch from theta to the rolling circle replication might also limit access to the viral single-stranded DNA. The fact that no footprint was detected around the latency origin of replication, ori-P, points toward an A3-editing acting during lytic replication. The strategy deployed by EBV and KSHV to cope with A3 restriction is somehow opposite to the one used by the papilloma and polyomaviruses. Indeed, EBV and KSHV actively protect their genome from the A3s as opposed to the papilloma and polyomaviruses which simply cope with a high mutational rate. We speculate here that the large size of the herpesvirus genome would not tolerate an unrestrained A3 activity. Finally, we identified several AID-footprinted genes in the EBV genome which supports recent observations made by Martinez et al. \[[@ppat.1008718.ref033]\]. Those genes are not spatially clustered and further investigation would be necessary to link the detected footprint to AID activity.

Similarly, we identified an A3 footprint on *adenoviridae* localized at the ends of their linear genome where the origins of replication are located. The presence of an A3 footprint on the lagging strand of the origins of replication and its absence on the leading strand is striking. It parallels the footprint on the lytic origins of replication in EBV and it is also reminiscent of the A3 activity in cancer genomes. Thus, A3-related mutations in cancer genomes are strongly enriched on the lagging strand and early-replicating euchromatic regions \[[@ppat.1008718.ref067]--[@ppat.1008718.ref070]\]. The leading strand, being protected by the nascent complementary DNA, is less or even not accessible for deamination. Another circumstance where the viral DNA is transiently single-stranded is during transcription. Indeed, the coding strand within the transcriptional bubble is temporally single stranded. In cancer genomes, the observed distribution of APOBEC3-signature mutations is transcription independent \[[@ppat.1008718.ref070]\]. Again, it is very similar to our observations on viral genomes where no evidence points toward A3-editing during viral transcription. Overall, the similarities between *adenoviridae* and *herpesviridae* regarding their relationship to A3s appear substantial. Both are large double-stranded DNA viruses replicating their genome in the nucleus and capable of lytic and latent/persistent phases. It would not be surprising to find that *adenoviridae* are also able to inhibit A3 activity. Along with these speculations, we found important to underline that the dependoparvovirus AAV-1 is the only member of the *parvoviridae* family which does not have an A3 footprint. It would be interesting to test whether it is an intrinsic characteristic of the satellite virus or whether it is mediated by the helper virus (usually an adenovirus or a herpes virus).

The detection of an A3 footprint on the negative strand of the C (Core) and preC/HBeAg coding sequences of HBV is compatible with A3-editing on the DNA negative strand during reverse transcription. A3-related mutations have been detected on the negative strand of the C and preC region and it has been proposed that these mutations could be beneficial for the virus \[[@ppat.1008718.ref071]\]. Indeed, during the natural course of HBV infection, the HBeAg expression is being lost after production of antibodies against it. HBeAg is an accessory non-particulate protein encoded by the preC mRNA and displaying immunomodulatory properties. HBeAg is described as a tolerogen that allows the virus to establish infection. Seroconversion against the HBeAg leads to the selection of HBeAg-negative mutants. The ability to develop mutations, altering HBeAg expression, can influence the length of the HBeAg-positive phase, which is important for determining the clinical course (reviewed in \[[@ppat.1008718.ref072]\]). Our observation of an A3 footprint in the preC and C region further supports the idea that A3 can positively participate to the immune escape. That would not be the first example of the hijacking an antiviral weapon for the benefit to the pathogen. Hepatitis D virus is a circular complementary single-stranded RNA virus that requires editing of its genome by a cellular adenosine deaminase (ADAR-1) to complete its life cycle (reviewed in \[[@ppat.1008718.ref073]\]). Likewise, it is striking to note that only the C and preC/HBeAg coding regions are being footprinted and not the others coding sequences downstream. In fact, the mutational load introduced by the A3s is much stronger on the 5' end of the negative strand (corresponding to the Pol, S and X regions) because the newly synthesized double strand DNA eventually displaces the single strand DNA from the capsid walls, making it accessible to deaminase activity \[[@ppat.1008718.ref074]\]. Thus, the 5' end of the negative strand is found to be frequently hypermutated; the term hypermutation referring to as mutations clustered on a short sequence. It is essential to underline that our observations reflect the A3-induced mutations which were conserved and not those which put an end to the viral cycle. Consequently, the phenomenon of hypermutation will not leave an evolutionary footprint. In this respect, the HBV mutation spectrum from *in vivo* cirrhotic samples shows that even though the majority of HBV genomes are strongly mutated by A3s and these virions are probably defective, a small fraction is slightly modified and may therefore still be infectious \[[@ppat.1008718.ref071]\]. Finally, the Pol, S and X genes overlap on different reading frames, which implies that these coding regions are less permissive to mutations (a silent mutation in one frame may not be in the other frame).

We paid particular attention to HIV in our analysis as the APOBEC3 antiviral activity has been historically discovered in that field of research \[[@ppat.1008718.ref006]\]. We observed a weak A3 evolutionary footprint on the minus strand of the HIV genomes in support of the observations made by Jern et al. \[[@ppat.1008718.ref031]\]. The weakness of the footprint can be explained at least in part by the efficiency of the A3-inhibiting protein Vif. Also, the error-prone RT could be responsible for the reversion of some A3-induced mutations providing that the virus can still complete its life cycle. Finally, A3s are well known to also restrict HIV through a deaminase independent activity, therefore without leaving any footprint.

The intensity of the A3 footprint is very strong in many *papillomaviridae* and *polyomaviridae*. Several viruses of these families are well-known tumor viruses (HPV-16, HPV-18, Merkel cell polyomavirus, etc.) and a mechanistic link between A3 expression and the development of cancer has been established in HPV positive cervical and oesopharyngeal cancers \[[@ppat.1008718.ref075],[@ppat.1008718.ref076]\]. [S12 Fig](#ppat.1008718.s012){ref-type="supplementary-material"} shows oncogenic viruses (confirmed or suspected) and their respective A3 footprint. It illustrates that an A3 footprint is not present in every tumor virus. HCV shows no A3-footprint, is still definitely a tumor virus. Nevertheless, we wonder whether the presence of a strong footprint may suggest involvement in cancer. The BK and JC polyomaviruses have a footprint as intensive as HR-HPVs ([S12 Fig](#ppat.1008718.s012){ref-type="supplementary-material"}). BK PyV infects the kidneys and the urinary tract and is suspected of playing a role in certain bladder cancer where viral expression and integration have been reported \[[@ppat.1008718.ref077],[@ppat.1008718.ref078]\]. BK PyV triggers A3 expression *in vitro* and the A3-related mutations found in bladder tumors account for two-thirds of the total mutational load \[[@ppat.1008718.ref017],[@ppat.1008718.ref079]\]. Similarly, along with the *alpha*, the *beta-papillomaviridae* show a similar A3 footprint ([Fig 4B](#ppat.1008718.g004){ref-type="fig"}). Some members of the *beta-papillomavirus* genus are suspected to play a role in non-melanoma skin cancer (cutaneous squamous-cell carcinoma) \[[@ppat.1008718.ref080],[@ppat.1008718.ref081]\]. Even so they do not seem to insert into the cell genome, they might promote carcinogenesis initiation. Some β-HPVs were demonstrated to potentiate the deleterious effect of UV radiations and to drive skin carcinogenesis in mice with a hit-and-run mechanism \[[@ppat.1008718.ref082]\]. Finally, the erythroparvovirus B19 is one of the most footprinted virus. While its replication occurs primarily in erythroid tissues, the erythroparvovirus B19 commonly persists in a wide range of tissues \[[@ppat.1008718.ref083]\]. A link between the erythroparvovirus B19 and thyroid cancer has been proposed but evidence is scarce to date (72--74). Of note, the A3-related mutations in thyroid tumors make about 40% of the total mutational load \[[@ppat.1008718.ref079]\]. We think that further research should be carried out to rule in or out the involvement of these later viruses in cancer.

In conclusion, the present study represents the first global screening for the A3 selection pressure on all currently annotated human viruses. We demonstrate that many *papillomaviridae*, *polyomaviridae*, autonomous *parvoviridae* and *coronaviridae* can thrive despite being under the selective pressure of the A3 proteins. Those viruses cope with A3 editing activity thanks to a deep cleansing of A3-favored motifs in their genome. *Herpesviridae* and *adenoviridae* display a subtler A3 footprint limited to the lytic origins of replication, probably thanks to active mechanisms of A3 inhibition. A3 deamination appears to occur during replication of viral DNA (sometimes limited to the lagging strand) for the double-stranded DNA viruses and/or inside the capsid for the single-stranded DNA and RNA viruses. The causal link established between HPV infection and the A3 mutational signature in human cancer also lead us to propose to consider the *beta-papillomaviridae* and the erythroparvovirus B19 as potentially promoting A3 expression and therefore exposing the cell genome to a mutagenic activity.

Material and methods {#sec014}
====================

Fasta sequences {#sec015}
---------------

We downloaded complete viral genomes from the "NCBI Virus" database (<https://www.ncbi.nlm.nih.gov/labs/virus/vssi/#/>) as released in April 2020. We retrieved only full-length genomes by selecting "Complete" for the criterion "Nucleotide Completeness". We retrieved Human viruses by selecting "Humans" for the criterion "Host". We retrieved non-human primate viruses by selecting "Primate" for the criterion "Host" and by deducting the human viruses from this data set. We retrieved avian viruses by selecting "Aves (birds)" for the criterion "Host". We retrieved fish viruses by selecting "Actinopterygii (ray-finned fish)" for the criterion "Host". We also retrieved Camel MERS viruses by selecting "Camelus dromedaries (Arabian Camel)" for the criterion "Host" and "MERS-CoV" for criterion "Virus". We retrieved Bat-MERS viruses by selecting "Chiroptera (bats)" for the criterion "Host" and "MERS-CoV" for the criterion "Virus". We retrieved Bat-SARS viruses by selecting "Chiroptera (bats)" for the criterion "Host" and "Severe acute respiratory syndrome-related coronavirus" for criterion "Virus". The dataset of Human viruses was supplemented by manually curated human virus complete genome sequences from the "NCBI nucleotide" database. Using these criteria, 33,400 Human, 1,397 non-human primate, 9,160 avian, 570 fish, 259 Camel MERS, 5 Bat MERS and 33 Bat SARS full-length viral genomes were collected. GenBank accession ID's are treated as unique and listed in the [S1](#ppat.1008718.s013){ref-type="supplementary-material"}, [S2](#ppat.1008718.s014){ref-type="supplementary-material"} and [S3](#ppat.1008718.s015){ref-type="supplementary-material"} Tables.

Calculation of the K-mer representation ratio {#sec016}
---------------------------------------------

A K-mer encompasses a collection of sequences with a common motif. For instance, the NTC K-mer includes the ATC, CTC, GTC and TTC sequences. In addition, as we limit our analysis to coding sequences, we force our K-mers to be in the reading frame and therefore to correspond to codons. For example, the NTC K-mer actually includes the ATC, CTC, GTC and TTC codons. Following the same logic, the NNTCNN K-mer comprises the 256 pair of codons having a T at the end of the first codon and a C to start the second codon. We calculated the observed vs. expected K-mer representation ratio as described by Warren *et al*. \[[@ppat.1008718.ref029]\]. Briefly, each coding sequence has been randomly shuffled a thousand times, retaining only the nucleotide composition. The expected count of a given K-mer is calculated as the average of the occurrences of this K-mer over the thousand iterations. The K-mer ratio is given as the log2 ratio of the observed occurrence of this K-mer to the expected occurrence. To calculate the ratio of a given K-mer for an entire viral genome, a "synthetic coding genome" was generated by concatenating the different coding sequences ([Fig 1B](#ppat.1008718.g001){ref-type="fig"}). The synthetic coding sequence is then randomly shuffled a thousand times and K-mer ratio calculated as above. A K-mer ratio \<\< 0 indicates K-mer under representation and a K-mer ratio equal to zero means that no representation bias is observed.

Statistical analysis {#sec017}
--------------------

Unpaired Student's t test has been used where appropriate. The results were considered statistically significant at a P-value of \<0.05. All boxplot, heatmap and map representations have been generated using ggplot R package.

Supporting information {#sec018}
======================

###### Search for A3G-footprinted human viruses.

A. A3G favors deamination of cytidine when preceded by another cytidine. The 5'CC dinucleotide motif is depicted in three possible codon contexts on both coding and template strand. Depending on the position of the mutated C, the C to T transition can be synonymous (S) or non-synonymous (NS). Proportion of S and NS mutations is reported when the two types of mutation can be produced. Because synonymous mutations are more likely to be retained, A3G-footprinted viruses should display to a stronger depletion of NCC codons compared to CCN or NNCCNN motifs (and/or a depletion of NNGGNN motifs versus the GNN and NGG motifs). B. The NCC and NNGGNN observed/expected ratios for 33,400 human viruses' genomes (from 870 unique species) were calculated, grouped by species and colored according to the Baltimore classification. Each point represents a unique viral genome. Viral species with an NCC or NNGGNN ratio below two times the standard deviation (dotted grey line) from the population median (red line) are retained for further analysis in panel C. C. The observed/expected ratios of 5'CC dinucleotide at various codon positions and on both strands (i.e. NNCCNN, CCN, NCC, GGN, NGG and NNGGNN) were calculated for the NCC and/or NNGGNN depleted viral species and depicted by a heatmap. A colored scale with increasing shades of blue indicating depletion and increasing shades of red indicating enrichment. P-values were calculated by Student's unpaired, two-tailed t-test (NS for not significant, \* p\< 0.05, \*\* p\< 0.01, \*\*\* p\< 0.001). D. List of the viral genes displaying NCC or NNGGNN depletion and belonging to an otherwise non-depleted viral genome.

(PDF)

###### 

Click here for additional data file.

###### NTC depletion among several *polyomaviridae* family members.

The observed/expected ratios of TC dinucleotide at various codon positions (i.e. NNTCNN, TCN, NTC) were calculated for several polyomaviruses and the corresponding genus (alpha, beta and delta) is reported for each virus.

(PDF)

###### 

Click here for additional data file.

###### K-mer ratios of the human viruses split according to Baltimore's groups.

Human viruses were broken down into their respective Baltimore's group and analyzed for their observed/expected K-mer ratios.

(PDF)

###### 

Click here for additional data file.

###### NTT, NTA and NTG K-mers ratios of the A3-footprinted viruses.

The observed/expected ratios of NTC, NTT, NTA and NTG K-mers were calculated for the putative A3-footprinted viral species and depicted by a heatmap. A colored scale with increasing shades of blue indicating depletion and increasing shades of red indicating enrichment. P-values were calculated by Student's unpaired, two-tailed t-test (NS for not significant, \* p\< 0.05, \*\* p\< 0.01, \*\*\* p\< 0.001).

(PDF)

###### 

Click here for additional data file.

###### TC depletion in HPV non-coding sequences.

The observed/expected ratios of TC dinucleotide at various "codon" positions (i.e. NNTCNN, TCN, and NTC) were calculated for the non-coding sequences of human papillomavirus 16, 18 and 31.

(PDF)

###### 

Click here for additional data file.

###### A3 footprint on HPV16, HPV18 and HPV31.

NTC and NNGANN observed/expected ratios were calculated for the different genes of the HPV16, HPV18 and HPV31 and were reported on their genomic maps using a colored scale with increasing shades of blue indicating NTC depletion and increasing shades of red indicating NTC enrichment. Replication origin is illustrated by a black dot and gene transcriptional orientation is symbolized by black arrow.

(PDF)

###### 

Click here for additional data file.

###### B19 erythroparvovirus genome is depleted for NNGANN K-mer.

Coding sequences (NS1, 7.5k, VP1, X, VP2 and 11k genes) from 18 full-length B19 erythroparvoviruses were depicted by grey lines overlaid by red marks to symbolize NNGANN and green marks to position NNAANN codons.

(PDF)

###### 

Click here for additional data file.

###### NTC depletion of the E1A and E4 genes of the Adenovirus A and B.

NTC observed/expected ratios were calculated for the different genes of the Adenovirus A and B and were reported on their genomic maps using a colored scale with increasing shades of blue indicating NTC depletion and increasing shades of red indicating NTC enrichment.

(PDF)

###### 

Click here for additional data file.

###### A3 footprint on Adenovirus C, D, E, F and G.

NTC and NNGANN observed/expected ratios were calculated for the different genes of the Adenoviruses C, D, F and G (each point represents a unique coding sequence).

(PDF)

###### 

Click here for additional data file.

###### Search for AID-footprinted viruses.

A. AID favors cytidine deamination in a 5' WRC context. The WRC trinucleotide motif is depicted in three possible codon contexts on both coding and template strand. Depending on the position of the mutated C, the C to T transition can be synonymous (S) or non-synonymous (NS). Proportion of S and NS mutations is reported when the two types of mutation can be produced. B. The WRC and NNGYWN observed/expected ratios for 33,400 human viruses' genomes (from 870 unique species) were calculated, grouped by species and colored according to the Baltimore classification. Each point represents a unique viral genome. C. List of the putative AID-footprinted viral genes (displaying WRC or NNGYWN depletion) and belonging to an otherwise non-depleted viral genome.

(PDF)

###### 

Click here for additional data file.

###### Search for APOBEC1-footprinted viruses.

A. APOBEC1 favors cytidine deamination in a 5' WCW context. The WCW trinucleotide motif is depicted in three possible codon contexts on both coding and template strand. Depending on the position of the mutated C, the C to T transition can be synonymous (S) or non-synonymous (NS). Proportion of S and NS mutations is reported when the two types of mutation can be produced. B. The NWCWNN and NWGWNN observed/expected ratios for 33,400 human viruses' genomes (from 870 unique species) were calculated, grouped by species and colored according to the Baltimore classification. Each point represents a unique viral genome. C. The observed/expected ratios of WCW trinucleotide at various codon positions and on both strands (i.e. NWCWNN, WCW, NNWCWN, NWGWNN, WGW and NNWGWN) were calculated for the NWCWNN and/or NWGWNN depleted viral species and depicted by a heatmap. A colored scale with increasing shades of blue indicating depletion and increasing shades of red indicating enrichment. P-values were calculated by Student's unpaired, two-tailed t-test (NS for not significant, \* p\< 0.05, \*\* p\< 0.01, \*\*\* p\< 0.001). D. List of the putative APOBEC1-footprinted viral genes (displaying NWCWNN or NWGWNN depletion) and belonging to an otherwise non-depleted viral genome.

(PDF)

###### 

Click here for additional data file.

###### A3 footprint in human oncogenic viruses.

NTC and NNGANN observed/expected ratios were calculated for each available coding sequence of eleven well-known cancer-related viruses. Each point represents a unique viral coding sequence. The coding sequences are grouped and colored according to gene name.

(PDF)

###### 

Click here for additional data file.

###### Genomic K-mer ratios for human viruses.

Observed/expected K-mer ratios for each genomic human viral sequence (available for download at <https://doi.org/10.5061/dryad.n8pk0p2sd>).

(TXT)

###### 

Click here for additional data file.

###### Genic K-mer ratios for human viruses.

Observed/expected K-mer ratios for each genic human viral sequence (available for download at <https://doi.org/10.5061/dryad.n8pk0p2sd>).

(ZIP)

###### 

Click here for additional data file.

###### Genomic K-mer ratios for non-human viruses.

Observed/expected K-mer ratios for each genomic and genic non-human viral sequence (available for download at <https://doi.org/10.5061/dryad.n8pk0p2sd>).

(TXT)

###### 

Click here for additional data file.

We thank members of the URVI lab for valuable discussions.
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Dear Dr gillet,

Thank you very much for submitting your manuscript \"Footprint of the host restriction factors APOBEC3 on the genome of human viruses\" for consideration at PLOS Pathogens. As with all papers reviewed by the journal, your manuscript was reviewed by members of the editorial board and by several independent reviewers. In light of the reviews (below this email), we would like to invite the resubmission of a significantly-revised version that takes into account the reviewers\' comments.

We cannot make any decision about publication until we have seen the revised manuscript and your response to the reviewers\' comments. Your revised manuscript is also likely to be sent to reviewers for further evaluation.

When you are ready to resubmit, please upload the following:

\[1\] A letter containing a detailed list of your responses to the review comments and a description of the changes you have made in the manuscript. Please note while forming your response, if your article is accepted, you may have the opportunity to make the peer review history publicly available. The record will include editor decision letters (with reviews) and your responses to reviewer comments. If eligible, we will contact you to opt in or out.

\[2\] Two versions of the revised manuscript: one with either highlights or tracked changes denoting where the text has been changed; the other a clean version (uploaded as the manuscript file).

Important additional instructions are given below your reviewer comments.

Please prepare and submit your revised manuscript within 60 days. If you anticipate any delay, please let us know the expected resubmission date by replying to this email. Please note that revised manuscripts received after the 60-day due date may require evaluation and peer review similar to newly submitted manuscripts.

Thank you again for your submission. We hope that our editorial process has been constructive so far, and we welcome your feedback at any time. Please don\'t hesitate to contact us if you have any questions or comments.

Sincerely,

Paul Francis Lambert

Associate Editor
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Karl Münger
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Kasturi Haldar
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\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*

Reviewer\'s Responses to Questions

**Part I - Summary**

Please use this section to discuss strengths/weaknesses of study, novelty/significance, general execution and scholarship.

Reviewer \#1: The manuscript "Footprint of the host restriction factors APOBEC3 on the genome of human viruses\" by Poulain et al. expands upon previous work on classifying the depletion of APOBEC3 target motifs in over 24,000 human viruses and some non-human primate, avian, and fish viruses. Using methods adapted and expanded from Warren et al., the authors first validate that their analysis supports significant APOBEC3-motif depletion in polyomaviruses and papillomaviruses. They then identify that more viruses are depleted for this motif generally across their genomes. Additionally, some viruses that would normally not be considered depleted have significant depletion in certain regions of their genomes consistent with viral genome replication or transcription, such as adenoviruses and herpesviruses. This study is thorough and is an important comparison of APOBEC depletion using the same analysis approach across many virus families. There are some major concerns that need to be addressed first before I would recommend this interesting manuscript for acceptance.

Reviewer \#2: To my knowledge this is the first valiant attempt to comprehensively analyze the APOBEC mutation signature across "all" viruses. This pan-virome analysis confirmed the documented presence of an APOBEC footprint on many viruses, most notably polyoma viruses and papillomaviruses. The approach also shed light on some less characterized APOBEC substrates including erythroviruses and coronaviruses (though curiously not those that recently zoonosed including human SARS-CoV-2). A gene-centric modification of the approach also indicated some interesting correlations with gamma-herpesvirus and adenovirus DNA replication strategies. Overall, the authors estimate an APOBEC impact on 16% of "all" viruses (though this number may be debatable because not all RNA viruses seem to be analyzed here).

Reviewer \#3: Poulain and colleagues use a computational approach to identify a decrease in TC dinucleotides in a variety of viral genomes. The authors suggest that the decrease in TC, specifically NTC, represents an APOBEC3 footprint in these viral genomes. This has the potential of being a really interesting story, but the authors need to address a couple of concerns before publication is warranted.

\*\*\*\*\*\*\*\*\*\*

**Part II -- Major Issues: Key Experiments Required for Acceptance**

Please use this section to detail the key new experiments or modifications of existing experiments that should be [absolutely]{.ul} required to validate study conclusions.

Generally, there should be no more than 3 such required experiments or major modifications for a \"Major Revision\" recommendation. If more than 3 experiments are necessary to validate the study conclusions, then you are encouraged to recommend \"Reject\".

Reviewer \#1: The taxonomic labeling of the supplemental tables is incorrect. The genus column contains family and subfamily classifications. The family column contains genus and the species column contains both species, type and strain. It is unclear how these discrepancies may have affected data analysis and plotting.

Additionally, I found an error in the annotation of one virus in the supplemental excel file. There may be more that could minorly affect the results:

ssRNA viruses Flaviviridae Alphapapillomavirus Tick-borne encephalitis virus

The authors should add more detail in the methods as to how the viral sequences were selected. Were identical sequences collapsed?

I'm not fully convinced that the Student's t-test of NTC/NNGANN versus TCN/NGA & NNTCNN/GAN is a necessary comparison. What is the biological take home message from these comparisons?

Reviewer \#2: Major

1\) At multiple points the authors claim to have analyzed "all" human viruses. This is obviously a moving target with many new viruses being reported each year (ex. thousands in one paper alone from a recent paper by the Buck lab -- PMID 32014111 -- which could alone change the results of the present study). Therefore, I suggest tempering this claim to "all currently annotated viruses" or all "NCBI references viruses" (and state the download window or dates in the methods).

2\) Lines 190-92 indicate no depletion of A3G preferred NCC sites in viruses. A close look at Fig 3b shows some viruses with a clear underrepresentation of NCC sites. Are these retros? The authors should also comment on outliers that maybe impacted by A3G. In other words, the wholistic view is appreciated but a closer look at exceptions would also help balance the story.

3\) Authors should extend analyses of gene-level footprints to include A3G-preferred motifs (in the very least as an additional negative control).

4\) To be as comprehensive as possible, the authors should also consider including the footprint of AID in this analysis, as the only family member preferring purine nucleobases on the 5' side of the target cytosine (RC).

5\) HIV-1, HIV-2 and SIV should be have a dedicated results subsection and should be included in intraviral comparisons such as those in fig S6. The APOBECs were discovered as retrovirus restriction factors and they continue to have an impact on these viruses. The paper cites contrasting publications on the APOBEC footprint in retroviruses and I'm curious what the results are using the methodology described here in this ms.

6\) A supplementary table of all downloaded file accession numbers should be included to enable full reproducibility.

Reviewer \#3: 1. My main concern is related to how the 'synthetic genomes' are constructed by concatenating the different coding genes. It is not clear how overlapping genes are handled. It is clear that selection will work differently when 2 genes overlap. E.g. TCN in frame 1 = NTC in frame 2. However, a change in frame 2, will have a huge impact in frame 1 and will likely not be tolerated. The authors need to take this into account in their analysis. This is particularly important for the gene level analysis presented in figures 7, 8, 9 and 10. For example, is HBZ really affected by APOBEC, or is the apparent los of TCs due to being the sole gene on the opposite strand, while being in an intron for 3 other genes?

2\. I would like the authors to include a control for non-coding sequences. If the loss of NTC is truly correlated with the degenerate DNA code, one would expect that all TC, regardless of codon position, will be affected.

3\. APOBEC3 typically converts TC to TTT. The authors do not provide evidence that TC reduction is accompanied by an increase in TT. I would like to see this data. Specifically, in the case of the Coronaviridae where the evidence in favor of APOBEC mutations is, in my opinion, minimal (see next comment).

4\. The data in figure 4 is used to argue that in addition to dsDNA viruses, members of the Coronaviridae have reduced NTC content. The authors use two standard deviations around the mean of a bimodal distribution. The logic behind this choice is not completely obvious to me. It is clear that the average of this bimodal distribution is heavily skewed by a large group of viruses that are not TC depleted. However, there is minimal evidence that RNA is a substrate for APOBEC3. Indeed, there is more convincing evidence that APOBEC does not edit RNA. Therefore, the distribution is artificially skewed towards 0, which affects the validity of the 2xSD approach. I would like the authors to use a different approach to show that the TC depletion of HKU is real. Moreover, a recent paper showing that APOBEC3 restricst coronavirus replication, also showed no evidence of hypermutation upon overexpression of APOBEC, but points towards a non-canonical APOBEC function (1).

5\. The authors suggest a difference between human CoV and zoonotic CoVs. The authors need to take the evolutionary history of these viruses into account. Furthermore, bats have a significantly expanded APOBEC repertoire compared to humans, so the authors need to explain why bat APOBEC would not edit the CoV genomes, but human APOBECs do.

\(1\) 1) Milewska, A., Kindler, E., Vkovski, P. et al. APOBEC3-mediated restriction of RNA virus replication. Sci Rep 8, 5960 (2018). <https://doi.org/10.1038/s41598-018-24448-2>

\*\*\*\*\*\*\*\*\*\*

**Part III -- Minor Issues: Editorial and Data Presentation Modifications**

Please use this section for editorial suggestions as well as relatively minor modifications of existing data that would enhance clarity.

Reviewer \#1: Line 100: this should be tempered to be representatives from all known human virus families. The authors do not have all papillomavirus types (400+) and therefore cannot claim all viruses.

Considering the previous point, the claim that 16% of all viruses being A3-motif depleted may be incorrect. How was this calculated initially?

Figure 9. Is RPMS1 completely depleted or is this an error? The other ORFs that are labeled black in panel A should be a color that is not on the k-mer ratio color scale.

Lines 370-378: Non-human coronaviruses do not show a TC depletion signature, but do they show evidence for deamination by bat APOBECs? Bat retroviruses show more mutation for GG to AG rather than GA to AA according to Hayward et al. Mol. Biol. Evo. 2018. Unfortunately the RPo assay used in that paper doesn't comprehensively test all C containing trinucleotides, so there is not a clear motif preference for each bat APOBEC3, but could be potentially inferred by expanding the motif analysis beyond TC.

In a similar vein to the previous comment, is it possible that APOBEC1 (target motif: YCY) is the primary DNA deaminase against viruses in the absence of APOBEC3 enzymes? What about AID (WRCN)?

Potentially out of the scope of this paper, but I am curious whether any mouse viruses show mouse APOBEC3 motif depletion (TYCN)?

The sentence on line 249 is unclear: "Nevertheless, the observation of a general depletion of the NGA codons precludes any conclusion regarding the presence of an A3 footprint on the negative strand (Fig 6)\"

I completely agree that NTC/NNGANN is a benchmark for APOBEC3 activity on viruses over evolutionary time. Can the authors speculate on whether viruses with depletions in TC/GA motifs that would otherwise result in coding changes are more protected against APOBEC3 activity and therefore in less need of anti-APOBEC proteins such as Vif or BORF2.

Parvovirus B19 also perturbs the cell cycle and E2F family of genes through NS1 (PMID: 20890043, PMID: 282640280). For BKPyV (and likely relatives) this function seems to be essential for APOBEC3B upregulation. Does this differ from other parvoviruses as a potential explanation for the observed APOBEC3 motif depletion?

Do the codons in the Parvovirus B19 genome that overlap the 7.5k protein encode conserved amino acids for function or are these diverse?

Line 358: The sentence "This observation came as a half surprise.\" Is unnecessary.

References 34 and 38 out of order in the text.

428: edition should be editing

Reviewer \#2: Minor

\- The animal pictures are not necessary in Fig 6.

\- Line 363 -- "Parallelly" is not a word; try "In parallel" instead.

\- Line 428 -- "edition" is not a word; use "editing" instead.

\- Nomenclature -- use accepted names recent zoonotic virus - SARS-CoV-2 or COVID-19; not the much less common "Wuhan seafood market pneumonia virus").

\- The references are not yet in the correct format for PLoS Pathogens (and some like \#5 and \#11 and others are incomplete)

Reviewer \#3: 1. The authors should consider moving Figure 1 and the associated paragraph moved to materials and methods.

2\. Overall the figures are overly complicated. I do not feel like they really convey the results in an optimal manner. I would urge the authors to use less figures and improve their interpretability.

3\. Figure 2, The authors conclude that both strands are edited. It is however clear that NTC is significantly less common than NNGANN. This should be addressed.

4\. The authors compare human viruses to viruses in other groups of organisms. The authors should do this comparison for individual Baltimore classes. However, given the data in figure 4, it may not be relevant to compare anything but dsDNA viruses. Figure 3 should include some sort of statistical support.

\*\*\*\*\*\*\*\*\*\*

PLOS authors have the option to publish the peer review history of their article ([what does this mean?](https://journals.plos.org/plospathogens/s/editorial-and-peer-review-process#loc-peer-review-history)). If published, this will include your full peer review and any attached files.

If you choose "no", your identity will remain anonymous but your review may still be made public.

**Do you want your identity to be public for this peer review?** For information about this choice, including consent withdrawal, please see our [Privacy Policy](https://www.plos.org/privacy-policy).

Reviewer \#1: No

Reviewer \#2: No

Reviewer \#3: No

[Figure Files:]{.ul}

While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, [[https://pacev2.apexcovantage.com](https://pacev2.apexcovantage.com/)]{.ul}. PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email us at [<figures@plos.org>]{.ul}.

[Data Requirements:]{.ul}

Please note that, as a condition of publication, PLOS\' data policy requires that you make available all data used to draw the conclusions outlined in your manuscript. Data must be deposited in an appropriate repository, included within the body of the manuscript, or uploaded as supporting information. This includes all numerical values that were used to generate graphs, histograms etc.. For an example see here on PLOS Biology: <http://www.plosbiology.org/article/info%3Adoi%2F10.1371%2Fjournal.pbio.1001908#s5>.

[Reproducibility:]{.ul}

To enhance the reproducibility of your results, PLOS recommends that you deposit laboratory protocols in protocols.io, where a protocol can be assigned its own identifier (DOI) such that it can be cited independently in the future. For instructions see [[http://journals.plos.org/plospathogens/s/submission-guidelines\#loc-materials-and-methods](http://journals.plos.org/plospathogens/s/submission-guidelines)]{.ul}
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Click here for additional data file.
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19 Jun 2020

Dear Dr gillet,

We are pleased to inform you that your manuscript \'Footprint of the host restriction factors APOBEC3 on the genome of human viruses\' has been provisionally accepted for publication in PLOS Pathogens.

Before your manuscript can be formally accepted you will need to complete some formatting changes, which you will receive in a follow up email. A member of our team will be in touch with a set of requests.

Please note that your manuscript will not be scheduled for publication until you have made the required changes, so a swift response is appreciated.

IMPORTANT: The editorial review process is now complete. PLOS will only permit corrections to spelling, formatting or significant scientific errors from this point onwards. Requests for major changes, or any which affect the scientific understanding of your work, will cause delays to the publication date of your manuscript.

Should you, your institution\'s press office or the journal office choose to press release your paper, you will automatically be opted out of early publication. We ask that you notify us now if you or your institution is planning to press release the article. All press must be co-ordinated with PLOS.

Thank you again for supporting Open Access publishing; we are looking forward to publishing your work in PLOS Pathogens.

Best regards,

Paul Francis Lambert

Associate Editor
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Karl Münger

Section Editor
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Kasturi Haldar

Editor-in-Chief
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\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*

Reviewer Comments (if any, and for reference):

Reviewer\'s Responses to Questions

**Part I - Summary**

Please use this section to discuss strengths/weaknesses of study, novelty/significance, general execution and scholarship.

Reviewer \#1: The authors\' revisions have adequately addressed all of my concerns.

Reviewer \#2: This is a comprehensive analysis of the APOBEC footprint in all available viral sequences. The authors have addressed my concerns fully.

\*\*\*\*\*\*\*\*\*\*

**Part II -- Major Issues: Key Experiments Required for Acceptance**

Please use this section to detail the key new experiments or modifications of existing experiments that should be [absolutely]{.ul} required to validate study conclusions.

Generally, there should be no more than 3 such required experiments or major modifications for a \"Major Revision\" recommendation. If more than 3 experiments are necessary to validate the study conclusions, then you are encouraged to recommend \"Reject\".

Reviewer \#1: None

Reviewer \#2: None

\*\*\*\*\*\*\*\*\*\*

**Part III -- Minor Issues: Editorial and Data Presentation Modifications**

Please use this section for editorial suggestions as well as relatively minor modifications of existing data that would enhance clarity.

Reviewer \#1: None

Reviewer \#2: None

\*\*\*\*\*\*\*\*\*\*

PLOS authors have the option to publish the peer review history of their article ([what does this mean?](https://journals.plos.org/plospathogens/s/editorial-and-peer-review-process#loc-peer-review-history)). If published, this will include your full peer review and any attached files.

If you choose "no", your identity will remain anonymous but your review may still be made public.

**Do you want your identity to be public for this peer review?** For information about this choice, including consent withdrawal, please see our [Privacy Policy](https://www.plos.org/privacy-policy).

Reviewer \#1: No

Reviewer \#2: No
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27 Jul 2020

Dear Dr gillet,

We are delighted to inform you that your manuscript, \"Footprint of the host restriction factors APOBEC3 on the genome of human viruses,\" has been formally accepted for publication in PLOS Pathogens.

We have now passed your article onto the PLOS Production Department who will complete the rest of the pre-publication process. All authors will receive a confirmation email upon publication.

The corresponding author will soon be receiving a typeset proof for review, to ensure errors have not been introduced during production. Please review the PDF proof of your manuscript carefully, as this is the last chance to correct any scientific or type-setting errors. Please note that major changes, or those which affect the scientific understanding of the work, will likely cause delays to the publication date of your manuscript. Note: Proofs for Front Matter articles (Pearls, Reviews, Opinions, etc\...) are generated on a different schedule and may not be made available as quickly.

Soon after your final files are uploaded, the early version of your manuscript, if you opted to have an early version of your article, will be published online. The date of the early version will be your article\'s publication date. The final article will be published to the same URL, and all versions of the paper will be accessible to readers.

Thank you again for supporting open-access publishing; we are looking forward to publishing your work in PLOS Pathogens.

Best regards,

Kasturi Haldar

Editor-in-Chief

PLOS Pathogens
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Michael Malim

Editor-in-Chief

PLOS Pathogens
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